B- Method for predicting of resistance against therapeutic agent in diffuse large B-cell lymphoma patients

摘要

The present invention relates to a composition for predicting drug resistance in patients with diffuse large B-cell lymphoma and a method for predicting resistance using the same. More specifically, the present invention relates to a diffuseness comprising an agent detecting a mutation of a specific gene and / or a copy number variation of a specific gene. The present invention relates to a composition for predicting drug resistance in patients with giant B-cell lymphoma and a prediction method using the same. By predicting treatment resistance through mutation of a specific gene and / or increasing or decreasing the number of copies of a specific gene provided in the present invention, it is possible to quickly and accurately predict the drug reactivity of individual patients with diffuse large B-cell lymphoma, thereby preventing unnecessary drug treatment. It can alleviate the physical, mental and economic pain of the patient, which is very meaningful given the quality of life during the patient's treatment.